Skip to main content
Fig. 4 | Alzheimer's Research & Therapy

Fig. 4

From: Characterization of FRM-36143 as a new γ-secretase modulator for the potential treatment of familial Alzheimer’s disease

Fig. 4

FRM-36143 increases the fourth cleavage step of gamma secretase. Using the step-wise cleavage model for Aβ cleavage, the generation of the tetrapeptide VVIA (Aβ42 → Aβ38) and of the pentapeptide VVIAT (Aβ43 → Aβ38) is increased by FRM-36143 in HEK cells expressing WT presenilin. Data represent mean ± SEM of n = 4. Unpaired t test: ** p < 0.01, *** p < 0.001

Back to article page